Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

AIDS conference serves as forum for highlighting new Vertex/Glaxo Wellcome HIV protease inhibitor

Feb. 5, 1999

AT1-targeted antisense approach to hypertension validated in vitro and in vivo

Feb. 5, 1999

Preliminary clinical results presented for YM-872, a potential therapeutic for stroke

Feb. 5, 1999

CNS-5161 safe for further clinical evaluation as a neuroprotective agent

Feb. 5, 1999

Overview of phase II trials of GV-150526 presented

Feb. 5, 1999

Progenics identifies novel anti-HIV product

Feb. 4, 1999

Single-dose phase I/II trial results in HIV+ adults given PRO-542 presented

Feb. 4, 1999

Agouron's new anti-HIV compounds profiled at AIDS conference

Feb. 4, 1999

Promising early clinical results presented this week for ABT-378 in combination with ritonavir

Feb. 4, 1999

Combinations of K-12 and other anti-HIV compounds tested in vitro for synergy

Jan. 7, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...